Value | Training cohort | Validation cohort | ||||||
All patients n=127 | Survivors n=92 | Non-survivors n=35 | P value | All patients n=80 | Survivors n=62 | Non-survivors n=18 | P value | |
Age | 74 (20–94) n=127 | 74 (20–94) n=92 | 73 (38–93) n=35 | 0.552 | 62 (23–90) n=80 | 59 (23–89) n=62 | 76 (36–90) n=18 | 0.002 |
Male | n=72/127 (56.7%) | n=49/92 (53.3%) | n=23/35 (65.7%) | 0.234 | n=45/80 (56.3%) | n=35/62 (56.5%) | n=10/18 (55.6%) | 0.578 |
Living conditions | n=127 | 0.877 | ||||||
At home | n=82 (64.6%) | n=58 (63.0%) | n=24 (68.6%) | |||||
Nursing home | n=18 (14.2%) | n=14 (15.2%) | n=4 (11.4%) | |||||
Other clinic | n=27 (21.3%) | n=20 (21.7%) | n=7 (20.0%) | |||||
Hospitalisation <3 months | n=64/127 (50.4%) | n=49/92 (53.3%) | n=15/35 (42.9%) | 0.326 | ||||
Nosocomial infection | n=110/127 (86.6%) | n=77/92 (83.7%) | n=33/35 (94.3%) | 0.151 | n=60/80 (75.0%) | n=44/62 (71.0%) | n=16/18 (88.9%) | 0.214 |
Charlson Comorbidity Index≥3 | n=109/127 (85.5%) | n=76/92 (82.6%) | n=33/35 (94.3%) | 0.152 | ||||
Prior antibiotic treatment | n=78/127 (61.9%) | n=55/92 (60.4%) | n=23/35 (65.7%) | 0.684 | ||||
Diagnosis on normal ward | n=94/127 (74.0%) | n=71/92 (77.2%) | n=23/35 (65.7%) | 0.257 | n=58/80 (72.5%) | n=48/62 (77.4%) | n=10/18 (55.6%) | 0.08 |
CRP in mg/L | 114.25 (3.0–436.0) n=120 | 99.5 (3.0–289.0) n=85 | 151.0 (6.8–436.0) n=35 | 0.003 | 123.92 (1.9-452.4) n=58 | 115,3 (1.9–371.4) n=43 | 150.3 (14.7–452.4) n=15 | 0.265 |
WCC in x10ˆ9/L | 12.4 (0.0–70.1) n=125 | 11.6 (0.0–41.4) n=90 | 15.0 (0.1–70.1) n=35 | 0.064 | ||||
Temperature in °C | 37.2 (36.0–39.8) n=125 | 37.4 (36.0–39.8) n=91 | 37.15 (36.0–38.7) n=34 | 0.248 | ||||
Heartbeats/min | 84 (50–130) n=125 | 82 (50–118) n=91 | 90 (60–130) n=34 | 0.044 | ||||
Systolic blood pressure in mm Hg | 109 (60–170) n=125 | 110 (60–170) n=91 | 99.5 (65–138) n=34 | 0.002 | 125.54 (60-166) n=80 | 117.5 (60–166) n=62 | 110 (65–145) n=18 | 0.100 |
Breaths/min | 22 (11–32) n=37 | 21 (11–30) n=26 | 22 (12–32) n=11 | 0.402 | ||||
SIRS criteria fulfilled | n=63/94 (67.0%) | n=41/66 (62.1%) | n=22/28 (78.6%) | 0.153 |
Data are presented as mean (minimum–maximum) for continuous variables and absolute numbers (percentage) for discrete variables, respectively.
Crossed out parameters in the validation cohort were not systematically assessed.
CRP, C-reactive protein; SIRS, systemic inflammatory response syndrome ; WCC, white cell count.